Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > NanoSight launches the CFR21 part 11 compliant version of their nanoparticle characterization software

Abstract:
NanoSight, leading manufacturers of unique nanoparticle characterization technology, announces they have developed their NTA (Nanoparticle Tracking Analysis) software platform such that it may now be implemented within a CFR compliant environment.

NanoSight launches the CFR21 part 11 compliant version of their nanoparticle characterization software

Salisbury, UK | Posted on September 5th, 2011

CFR 21 Part 11 is the part of the CFR21 guidelines issued by the FDA related to electronic record keeping and is primarily aimed at the pharmaceutical industry. It pertains to a number of requirements for scientific instruments such as requiring that there are suitable levels of access for different user and manager levels within the organization, that records are stored in a protected way, and that data, if changed, should not replace or obscure the original data, and that the software has been developed in a responsible and reliable manner amongst others.

Speaking on this exciting news, NanoSight's Head of Development, Dr Patrick Hole, said, "In the last year or so, our software has reached a level of maturity that with the April release of the latest version of NTA (Nanoparticle Tracking Analysis), implementation of the CFR21 part 11 was readily achievable and timely. The software was already aligning towards a level of robustness required across all industries and this, coupled with the requirement from several of our industry customers to implement these changes, made it an important and natural extension to the software. This extension will allow these users and others in the field to move forward further with their use of the technology."

At the recent Protein Stability Conference held in Breckenridge, Colorado, senior FDA members broadly welcomed the growing appreciation of the emergence of the NTA technology onto the scene as a contributing technique in the characterization of levels of protein aggregation.

This implementation has been accelerated by the use of a customisable off-the-shelf CFR21 part 11 toolkit supplied by Process Analysis and Automation Ltd. Mike Collins, PAA, commented "PAA have a strong track record in precisely this field and we were happy to help NanoSight with bringing about this implementation". The software was readily integrated into NanoSight's existing NTA and automates many of the CFR requirements including all the user rights management and the digital signing and encryption of records.

CEO Jeremy Warren comments "CRF21 Part 11 compliance is a well-trodden path for analytical instrumentation in QA within Pharma; for us the timing is perfect, as we are introducing this just as customers are beginning to ask for it".

This follows on swiftly from the company's achievement in becoming ISO9001 certified last month and further demonstrates the ability of the company to rapidly adopt development and compliance.

To find out more about this implementation of the software and to see examples of it, please visit the company's web site. Also to learn more about particle characterization using NanoSight's unique nanoparticle tracking analysis solutions, visit the company website (www.nanosight.com) and register to receive the next issue of NanoTrail, the company's electronic newsletter.

####

About NanoSight
NanoSight delivers the world’s most versatile and proven multi-parameter nanoparticle analysis in a single instrument.

NanoSight’s “Nanoparticle Tracking Analysis” (NTA) detects and visualizes populations of nanoparticles in liquids down to 10nm, dependent on material, and measures the size of each particle from direct observations of diffusion. Particle size, concentration, Zeta potential and aggregation can all be analyzed while a fluorescence mode provides differentiation of labelled particles. This particle-by-particle methodology goes beyond traditional light scattering and other ensemble techniques in providing high-resolution particle size distributions.

NanoSight’s comprehensive characterization matches the demands of complex biological systems, hence its wide application in development of drug delivery systems, of viral vaccines, in nanotoxicology and in biodiagnostics. This real-time data gives insight into the kinetics of protein aggregation and other time-dependent phenomena in a qualitative and quantitative manner.

NanoSight has a growing role in biodiagnostics, being proven in detection and speciation of nanovesicles (exosomes) and microvesicles. As functionalized nanoparticles increasingly fulfill their potential in biodiagnostics, NanoSight is ever more the analytical platform of choice.

NanoSight demonstrates worldwide success through rapid adoption of NTA, having installed more than 300 systems worldwide with users including BASF, GlaxoSmithKline, Merck, Novartis, Pfizer, Proctor and Gamble, Roche and Unilever together with the most eminent universities and research institutes. In addition to this user base more than 250 third party papers citing NanoSight results consolidate NanoSight’s leadership position in nanoparticle characterization. For more information, visit the NanoSight website (www.nanosight.com).

About PAA
Process Analysis & Automation Ltd (PAA) work with pharmaceutical, biotechnology and healthcare organisations to significantly increase sample throughput and data accuracy of sample preparation and analysis. PAA manufacture and supply automated workcells, proprietary laboratory automation scheduling software (Overlord) and other equipment to facilitate this. Overlord, incorporates drivers for over 400 of the most widely used instruments and robots.

For more information, please click here

Contacts:
NanoSight Limited
Minton Park
London Road
Amesbury SP4 7RT
T +44 (0) 1980 676060
F +44 (0) 1980 624703


NetDyaLog Limited
39 de Bohun Court
Saffron Walden
Essex CB10 2BA
T +44 (0) 1799 521881
M +44 (0) 7843 012997

Copyright © NanoSight

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

JPK announces expansion of its global sales and service activities in China and USA April 15th, 2014

Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014

PAM-XIAMEN Offers UV LED wafer April 15th, 2014

Engineers develop new materials for hydrogen storage April 15th, 2014

Imaging

Catching the (Invisible) Wave: UC Santa Barbara researchers create a unique semiconductor that manipulates light in the invisible infrared/terahertz range, paving the way for new and enhanced applications April 11th, 2014

Agilent Technologies Announces Fourth NanoMeasure Scientific Symposium: National Center for Nanoscience and Technology in Beijing to Host Event April 10th, 2014

Hawk Trade Secures Funding and Development Capital for Nanotec Industries: Nanotec Industries successfully negotiates funding for development of nano-sized treatment and imaging delivery device facility through Hawk Trade April 3rd, 2014

New JEOL-Nikon MiXcroscopy Correlative Imaging Solution March 27th, 2014

Software

New Integrated Raman Spectroscopy & Imaging Software from CRAIC Technologies: CRAIC Technologies introduces Lambdafire-R™ integrated Raman microspectroscopy & imaging software for Windows 8 ® March 26th, 2014

First methodology to analyse nanometer line pattern images March 18th, 2014

Agilent Technologies to Demonstrate New PXI Functional Test System at IPC APEX EXPO March 17th, 2014

Thin Film Thickness Measurements of Sub-Micron Sampling Areas from CRAIC Technologies February 28th, 2014

Announcements

Tiny particles could help verify goods: Chemical engineers hope smartphone-readable microparticles could crack down on counterfeiting April 15th, 2014

A molecular approach to solar power: Switchable material could harness the power of the sun — even when it’s not shining April 15th, 2014

Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014

Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE